SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0000950170-24-022579
Filing Date
2024-02-29
Accepted
2024-02-28 21:55:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 FWP 2.28.2024_fwp.htm FWP 125363
2 GRAPHIC img235686124_0.jpg GRAPHIC 4603
  Complete submission text file 0000950170-24-022579.txt   133575
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filed by) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Subject) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-266720 | Film No.: 24698560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)